🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Bevacizumab - Medicines in Ireland

11 authorised products containing Bevacizumab, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 11 authorised medicines
MedicineActive substanceLicence holderStatus
Abevmy 25 mg/mL concentrate for solution for infusion
EU/1/20/1515/001-005
 Bevacizumab Biosimilar Collaborations Ireland Limited —
Alymsys 25 mg/mL concentrate for solution for infusion
EU/1/20/1509/001-002
 Bevacizumab Mabxience Research, S.L. —
Avastin 25 mg/ml concentrate for solution for infusion
EU/1/04/300/001-002
 Bevacizumab Roche Registration GmbH —
Avastin 25 mg/ml Concentrate for solution for infusion
EU/1/04/300/1-2
 Bevacizumab Roche Registration Limited —
Aybintio 25 mg/ml concentrate for solution for infusion
EU/1/20/1454/001
 Bevacizumab Samsung Bioepis NL B.V. —
Aybintio 25 mg/ml concentrate for solution for infusion
EU/1/20/1454/002
 Bevacizumab Samsung Bioepis NL B.V. —
Lytenava 25 mg/mL solution for injection
EU/1/24/1798/001
 Bevacizumab Outlook Therapeutics NL B.V. —
MVASI 25 mg/mL Concentrate for solution for infusion
EU/1/17/1246/001-002
 Bevacizumab Amgen Technology (Ireland) Unlimited Company —
Oyavas 25 mg/mL concentrate for solution for infusion
EU/1/20/1510/001-002
 Bevacizumab Stada Arzneimittel AG —
Vegzelma 25 mg/mL concentrate for solution for infusion
EU/1/22/1667/001-004
 Bevacizumab Celltrion Healthcare Hungary Kft. —
Zirabev 25 mg/ml concentrate for solution for infusion
EU/1/18/1344/001-002
 Bevacizumab Pfizer Europe MA EEIG —
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.